A year-round opportunity for exceptional Biotech founders to work closely with the 2048 Ventures team at the earliest stages of their journey. If accepted, you get $250K for 8% on a post-money SAFE.
Why join 2048 Ventures Biotech Studio?
We’ve run the world’s top accelerators – Techstars, IndieBio, Creative Destruction Lab and 500 Startups – and have invested in over 200 early stage startups. We know how to help exceptional founders at the earliest stage of their journey.
Here is what 2048 Ventures Biotech Studio will be like for you:
- You will have a highly personalized, 1-1 experience with all members of 2048 Ventures team, our circle of biotechnology industry experts, and our founders. The Studio is HIGHLY SELECTIVE – we work with no more than 4 teams at any given time.
- You will work very closely with us for 256 days, which is much longer than a typical accelerator, because good things – like startups – take time.
- You will be in an environment specifically geared towards biotech startups that traditionally don’t get a good support system in a generic accelerator. We will help with spinning technology out of university, navigating IP issues, selling into pharma and healthcare, selecting CROs, thinking through the tradeoffs between being a vertically integrated or platform company, choosing go-to-market, figuring out FDA strategy, and much more.
- If you are wrapping up your PhD or research, we are happy to help you figure out if there is a market opportunity, and the mechanics of the spin out. No one is too early to apply.
- If you already launched out of a university or left your job to start a company – that’s great – we will help you refine the product, introduce you to early customers, validate your go-to-market, help with the sales pitch, pricing, and financial modeling.
- You will get access to the 2048 Ventures community and resources, including access to our founder Slack, workshops, biotech channels, vendor specials, and much more.
- You will get world class fundraising support, because we are BEASTS when it comes to helping you get additional funding. We literally wrote the playbook on it! Once you are ready, we will work with you on your pitch deck, financial model, and other materials. We will help you save time by creating a relevant pipeline of prospective investors and will facilitate warm introductions for you.
- While you can apply year around, we might be at capacity. We will announce our next deadline in the Fall.
- You get straightforward funding. No additional common stock, no tricks, no gimmicks. Receive $250K on a post-money SAFE that will convert into 8% of preferred stock in the next equity round.
Application and Decision Process
- Apply by filling out this short application
- Receive acknowledgement email
- If selected, go through initial 30 minute screen
- Answer follow up questions via a Notion doc
- Follow up meeting focusing on technology
- Final meeting with 2048 Ventures Team
- Founder References
- Offer
- Sign the docs
- Get the money in your bank account
- All within 16 business days
What kind of startups should apply?
We would love to speak with all exceptional, visionary, passionate founders and scientists building the future of biotech. No one is too early or too late.
We look for complete teams with complementary skills and welcome all founders – whether you are working in the lab, writing code, creating hardware – or doing it all – we’d love to meet you.  We expect your team to be complete so that you can execute on all aspects of the business and go fast!
We can invest in US, Canadian or UK entities, so if your startup is currently not incorporated in one of those countries, we would expect you to create a US entity before you receive an investment from us.
We are specifically excited about startups building PLATFORM and INFRASTRUCTURE businesses in biotechnology.
Here are the broad themes we’ve been thinking about:
- bioproduction: novel production strains, QC automation, downstream processing innovations
- synthetic biology: novel DNA applications, biosecurity, metabolism design
- ‘omics: building datasets in microbiome, neural signaling, blood biomarkers, diagnostics
We are also very excited about innovation in: AI/ML applications for drug discovery, novel bioreactors, drug delivery, drug target discovery, genetic editing, microbiome, early disease detection, metabolic optimization, metabolome, novel biomarker discovery and diagnostics, regenerative medicine, neurotechnology, digital therapeutics and many others.
Visit website for details: https://www.2048.vc/blog/bio-studio